To investigate CBFB and SMARCC1 protein expression in normal and neoplastic tissues, IHC was applied to a commercial TMA (COCA 912-5-OL) containing tissue biopsies covering normal mucosa, adenoma, adenocarcinoma and liver metastases. This evidence concerns the gene SMARCC1 and adenocarcinoma.